Concepts (145)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Organ Transplantation | 11 | 2022 | 1157 | 1.530 |
Why?
|
Kidney Transplantation | 12 | 2022 | 4234 | 1.330 |
Why?
|
Graft Rejection | 10 | 2020 | 4445 | 0.970 |
Why?
|
Isoantibodies | 3 | 2019 | 674 | 0.660 |
Why?
|
Immunosuppressive Agents | 6 | 2024 | 4174 | 0.560 |
Why?
|
Tacrolimus | 2 | 2024 | 733 | 0.550 |
Why?
|
Living Donors | 2 | 2021 | 641 | 0.550 |
Why?
|
T-Lymphocytes, Regulatory | 5 | 2019 | 3080 | 0.500 |
Why?
|
Thrombotic Microangiopathies | 1 | 2015 | 123 | 0.440 |
Why?
|
Sodium Chloride, Dietary | 1 | 2015 | 293 | 0.410 |
Why?
|
Tissue and Organ Procurement | 1 | 2021 | 961 | 0.410 |
Why?
|
Immediate-Early Proteins | 1 | 2015 | 449 | 0.400 |
Why?
|
Aortic Stenosis, Supravalvular | 1 | 2011 | 28 | 0.370 |
Why?
|
Kidney Failure, Chronic | 2 | 2021 | 2471 | 0.320 |
Why?
|
Williams Syndrome | 1 | 2011 | 194 | 0.310 |
Why?
|
Hepatitis C, Chronic | 3 | 2022 | 1032 | 0.300 |
Why?
|
Graft Survival | 4 | 2019 | 3819 | 0.240 |
Why?
|
Drug Delivery Systems | 1 | 2015 | 2226 | 0.230 |
Why?
|
Heart Transplantation | 4 | 2021 | 3233 | 0.230 |
Why?
|
Hepatitis C | 2 | 2022 | 1584 | 0.180 |
Why?
|
Pandemics | 4 | 2022 | 8654 | 0.150 |
Why?
|
Chemokine CXCL9 | 1 | 2017 | 135 | 0.150 |
Why?
|
Substance Abuse, Intravenous | 1 | 2022 | 529 | 0.140 |
Why?
|
Glomerulonephritis | 1 | 2018 | 331 | 0.130 |
Why?
|
Chemokine CXCL10 | 1 | 2017 | 316 | 0.130 |
Why?
|
Receptor, Notch1 | 1 | 2019 | 496 | 0.130 |
Why?
|
Tissue Donors | 3 | 2022 | 2331 | 0.130 |
Why?
|
Kidney | 3 | 2022 | 7048 | 0.120 |
Why?
|
Health Resources | 1 | 2020 | 935 | 0.120 |
Why?
|
Vascular Diseases | 1 | 2022 | 1161 | 0.110 |
Why?
|
Antiviral Agents | 3 | 2022 | 3060 | 0.110 |
Why?
|
Histocompatibility | 1 | 2014 | 317 | 0.110 |
Why?
|
Serpins | 1 | 2015 | 247 | 0.110 |
Why?
|
Internationality | 1 | 2018 | 1001 | 0.100 |
Why?
|
Janus Kinases | 1 | 2013 | 248 | 0.100 |
Why?
|
Lymphocyte Function-Associated Antigen-1 | 1 | 2013 | 377 | 0.100 |
Why?
|
T-Lymphocytes | 3 | 2021 | 10194 | 0.100 |
Why?
|
Lectins, C-Type | 1 | 2015 | 585 | 0.100 |
Why?
|
Models, Immunological | 1 | 2013 | 513 | 0.090 |
Why?
|
T-Lymphocyte Subsets | 1 | 2019 | 1802 | 0.090 |
Why?
|
Complement System Proteins | 1 | 2014 | 736 | 0.090 |
Why?
|
Humans | 27 | 2024 | 761504 | 0.090 |
Why?
|
Cytotoxicity, Immunologic | 1 | 2014 | 1351 | 0.090 |
Why?
|
Liver Transplantation | 1 | 2022 | 2330 | 0.090 |
Why?
|
Vaccination | 1 | 2022 | 3384 | 0.090 |
Why?
|
Skin Transplantation | 1 | 2015 | 1083 | 0.080 |
Why?
|
Hepacivirus | 3 | 2022 | 1336 | 0.080 |
Why?
|
Inpatients | 1 | 2020 | 2548 | 0.080 |
Why?
|
Protein Kinase C | 1 | 2013 | 1202 | 0.080 |
Why?
|
Cell Adhesion Molecules | 1 | 2015 | 1600 | 0.080 |
Why?
|
HLA Antigens | 1 | 2014 | 1328 | 0.080 |
Why?
|
Desensitization, Immunologic | 1 | 2014 | 556 | 0.080 |
Why?
|
Acute Kidney Injury | 1 | 2021 | 1924 | 0.080 |
Why?
|
Immunologic Memory | 1 | 2015 | 1359 | 0.070 |
Why?
|
Th2 Cells | 1 | 2013 | 1060 | 0.070 |
Why?
|
T-Lymphocytes, Cytotoxic | 1 | 2015 | 1784 | 0.070 |
Why?
|
Fatigue | 1 | 2014 | 1552 | 0.070 |
Why?
|
Postoperative Complications | 2 | 2020 | 15631 | 0.070 |
Why?
|
Membrane Proteins | 2 | 2015 | 7856 | 0.070 |
Why?
|
Dendritic Cells | 2 | 2015 | 2747 | 0.070 |
Why?
|
Delayed Diagnosis | 1 | 2011 | 463 | 0.070 |
Why?
|
Renal Insufficiency, Chronic | 1 | 2021 | 2243 | 0.070 |
Why?
|
Heart | 1 | 2019 | 4404 | 0.070 |
Why?
|
Comorbidity | 1 | 2021 | 10508 | 0.070 |
Why?
|
Waiting Lists | 2 | 2022 | 765 | 0.070 |
Why?
|
Antibodies, Blocking | 2 | 2019 | 243 | 0.070 |
Why?
|
Immunoconjugates | 1 | 2013 | 954 | 0.060 |
Why?
|
Receptors, Cell Surface | 1 | 2015 | 2822 | 0.060 |
Why?
|
B-Lymphocytes | 1 | 2019 | 4758 | 0.060 |
Why?
|
Liver | 1 | 2021 | 7529 | 0.060 |
Why?
|
Cardiac Surgical Procedures | 1 | 2021 | 3627 | 0.060 |
Why?
|
Anemia | 1 | 2014 | 1509 | 0.060 |
Why?
|
Mice, Inbred C57BL | 4 | 2019 | 22169 | 0.060 |
Why?
|
Gene Expression | 1 | 2017 | 7581 | 0.060 |
Why?
|
TOR Serine-Threonine Kinases | 1 | 2013 | 2057 | 0.060 |
Why?
|
Interleukin-6 | 1 | 2013 | 3208 | 0.050 |
Why?
|
Mice, Inbred BALB C | 3 | 2019 | 6216 | 0.050 |
Why?
|
Lymphocyte Activation | 1 | 2013 | 5486 | 0.050 |
Why?
|
Middle Aged | 9 | 2024 | 220895 | 0.050 |
Why?
|
Graft vs Host Disease | 1 | 2015 | 3029 | 0.050 |
Why?
|
Genomics | 1 | 2017 | 5821 | 0.050 |
Why?
|
CD8-Positive T-Lymphocytes | 1 | 2015 | 4580 | 0.050 |
Why?
|
Aortic Valve | 1 | 2011 | 1955 | 0.050 |
Why?
|
Donor Selection | 1 | 2022 | 232 | 0.040 |
Why?
|
Practice Guidelines as Topic | 1 | 2017 | 7390 | 0.040 |
Why?
|
Animals | 6 | 2021 | 168459 | 0.040 |
Why?
|
Saliva | 1 | 2024 | 828 | 0.040 |
Why?
|
Mice | 5 | 2021 | 81525 | 0.040 |
Why?
|
Time Factors | 3 | 2015 | 39967 | 0.040 |
Why?
|
STAT5 Transcription Factor | 1 | 2019 | 265 | 0.040 |
Why?
|
Survival Analysis | 2 | 2021 | 10090 | 0.040 |
Why?
|
Female | 9 | 2024 | 392644 | 0.040 |
Why?
|
Pyrrolidines | 1 | 2019 | 338 | 0.040 |
Why?
|
Quinoxalines | 1 | 2019 | 296 | 0.040 |
Why?
|
Multiple Myeloma | 1 | 2014 | 5146 | 0.030 |
Why?
|
Adult | 7 | 2024 | 221177 | 0.030 |
Why?
|
Diagnosis, Differential | 1 | 2011 | 12974 | 0.030 |
Why?
|
Immunocompromised Host | 1 | 2020 | 856 | 0.030 |
Why?
|
Mice, Transgenic | 2 | 2019 | 9539 | 0.030 |
Why?
|
Male | 8 | 2024 | 360804 | 0.030 |
Why?
|
Antibodies | 1 | 2022 | 2418 | 0.030 |
Why?
|
Nephritis | 1 | 2015 | 145 | 0.030 |
Why?
|
Benzimidazoles | 1 | 2019 | 858 | 0.030 |
Why?
|
International Cooperation | 1 | 2020 | 1422 | 0.030 |
Why?
|
Transplantation, Homologous | 1 | 2022 | 4806 | 0.030 |
Why?
|
Plasmapheresis | 1 | 2014 | 206 | 0.030 |
Why?
|
Granzymes | 1 | 2015 | 277 | 0.030 |
Why?
|
Drug Combinations | 1 | 2019 | 2048 | 0.030 |
Why?
|
Young Adult | 4 | 2024 | 59243 | 0.030 |
Why?
|
Glomerular Filtration Rate | 1 | 2021 | 2176 | 0.020 |
Why?
|
Histocompatibility Antigens | 1 | 2013 | 464 | 0.020 |
Why?
|
Microscopy, Electron | 1 | 2015 | 2561 | 0.020 |
Why?
|
Aged | 5 | 2024 | 169289 | 0.020 |
Why?
|
Antibodies, Monoclonal, Murine-Derived | 1 | 2014 | 694 | 0.020 |
Why?
|
Cells, Cultured | 2 | 2019 | 18965 | 0.020 |
Why?
|
Immune Tolerance | 1 | 2019 | 2303 | 0.020 |
Why?
|
Mice, Mutant Strains | 1 | 2013 | 1749 | 0.020 |
Why?
|
Immunoglobulins, Intravenous | 1 | 2014 | 664 | 0.020 |
Why?
|
Sulfonamides | 1 | 2019 | 1978 | 0.020 |
Why?
|
Hemodynamics | 1 | 2019 | 4159 | 0.020 |
Why?
|
Cohort Studies | 2 | 2021 | 41487 | 0.020 |
Why?
|
Societies, Medical | 1 | 2020 | 3905 | 0.020 |
Why?
|
Treatment Outcome | 2 | 2014 | 64680 | 0.020 |
Why?
|
Communicable Diseases | 1 | 2014 | 875 | 0.020 |
Why?
|
Cell Survival | 1 | 2015 | 5791 | 0.010 |
Why?
|
Kaplan-Meier Estimate | 1 | 2014 | 6484 | 0.010 |
Why?
|
Signal Transduction | 2 | 2019 | 23445 | 0.010 |
Why?
|
Biopsy | 1 | 2015 | 6766 | 0.010 |
Why?
|
Lung | 1 | 2021 | 10000 | 0.010 |
Why?
|
United States | 2 | 2021 | 72334 | 0.010 |
Why?
|
Incidence | 1 | 2021 | 21353 | 0.010 |
Why?
|
Disease Models, Animal | 1 | 2021 | 18252 | 0.010 |
Why?
|
Registries | 1 | 2018 | 8224 | 0.010 |
Why?
|
Combined Modality Therapy | 1 | 2014 | 8529 | 0.010 |
Why?
|
Quality of Life | 1 | 2024 | 13367 | 0.010 |
Why?
|
Boston | 1 | 2014 | 9326 | 0.010 |
Why?
|
Gene Expression Regulation | 1 | 2019 | 11903 | 0.010 |
Why?
|
Risk Factors | 2 | 2021 | 74206 | 0.010 |
Why?
|
Predictive Value of Tests | 1 | 2015 | 15266 | 0.010 |
Why?
|
Follow-Up Studies | 1 | 2019 | 39106 | 0.010 |
Why?
|
Mice, Knockout | 1 | 2013 | 14414 | 0.010 |
Why?
|
Antibodies, Monoclonal | 1 | 2013 | 9177 | 0.010 |
Why?
|
Aged, 80 and over | 1 | 2018 | 58976 | 0.010 |
Why?
|
Retrospective Studies | 1 | 2021 | 80636 | 0.010 |
Why?
|
Neoplasms | 1 | 2014 | 22170 | 0.000 |
Why?
|
Concepts
(145)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(70)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_